Management of Multifocal Non-Clear Cell RCC

IKCS 2020: Non-Clear Cell RCC SessionПодробнее

First-line ICIs in advanced non-clear cell RCCПодробнее

Using Combination Therapy as Treatment of Non-Clear Cell RCCПодробнее

KCRS21: Non Clear Cell RCCПодробнее

Kidney Cancer: First Day Home HealingПодробнее

RCC MasterClass and Clinical Consult: Novel Immune and Targeted TherapiesПодробнее

Promising results of cabozantinib plus nivolumab in non-clear cell RCCПодробнее

Renal Mass Lesions for the FRCR ExamПодробнее

Combining lenvatinib & pembrolizumab for non-clear cell RCC: KEYNOTE-B61 study rationaleПодробнее

Non Clear-Cell Type RCCПодробнее

Review of the Data of Frontline Treatment for Non-Clear Cell Kidney CancerПодробнее

New tools for RCC treatmentПодробнее

Promising TKI-ICI combinations for non-clear cell RCCПодробнее

KEYNOTE-B61: Putting a Focus on Non-Clear Cell RCC TreatmentПодробнее

Ask The Expert About Non-Clear Cell Renal Cell Carcinoma (nccRCC) ManagementПодробнее

Molecular pathways and management options in RCCПодробнее

Treatment of Metastatic Non-Clear Cell Renal Cell CarcinomaПодробнее

Unanswered questions in the management of clear cell RCCПодробнее

Immunotherapy-based management of metastatic clear-cell and variant RCC: What can we achieve?Подробнее

Treating non-clear cell renal cell carcinoma patientsПодробнее